For over 20 years, physicians have been applying the DynaPulse noninvasive blood pressure and pulse wave monitoring system, including online hemodynamic profiling, Pulse Wave Analysis via DynaPulse Analysis Cloud (DAC). As a result, their diagnosis and treatment of hypertension and associated cardiovascular diseases (CVD) had improved. A summary was published in the DynaPulse website: The Physician's Reference

Most recently, Dr. Antonio Delgado-Almeida, M.D.* kindly shared with us his 15-year experience using DynaPulse in clinics, and his views on advanced methods and procedures for diagnosing and treating essential hypertension and CVD:

"The advantages and uniqueness of DynaPulse noninvasive blood pressure and hemodynamic profile monitoring system as a routine device in medical practices (nurse, paramedics, sport centers, elementary or high school building) and of course, in-house measuring for patients, and physicians in charge of them...

I) Other devices, assumed to be the BEST, could not be used for (1) prevention of hypertension (2) ambulatory hemodynamics in Heart Failure, (3) Assessment of Anti-hypertensive drug effects, i.e., Vascular  Compliance , resistance, LV stroke work, LV dP/dT and more. these are the facts of uniqueness with DynaPulse.

II) DynaPulse Hemodynamic Facts -- a) Aortic Pulse Wave Reflection in Systole: Nobody knows that are vascular marker of hypertension; b) Isometric Hand-Grip test:  Who ever knows that is abnormal in untreated hypertensives (all), hypertensive on drugs (48%) and in normotensive adolescents from hypertensive parents (25%); c) Who has ever conducted Ambulatory Hemodynamic profiling, in heart failure patients?

III) DynaPulse is the best innovation for Blood Pressure, comparing to what " thermometer " is for fever. In brief, the advanced methods with DynaPulse and inherited defect in RBC-K in hypertensive will become the major breakthrough in cardiovascular medicine, comparing to all published articles from 2013 up to Jan. 2014, in hypertension pathogenesis or management to identify, predict or effectively treat the hypertension."

Antonio


* Professor Antonio Delgado-Almeida, MD, FAHA, Director and Head of Hypertension Research Unit & Ion Transport Laboratory at the University of Carabobo Medical School, Valencia, Venezuela, has been applying DynaPulse in his clinic and research since 1996. He has worked with thousands of patients and developed the most advanced method, combining DynaPulse data with Red Blood Cell (RBC) potassium (K) monitoring, for diagnosing and treating essential hypertension and associated cardiovascular diseases (CVD).